2,003
Views
13
CrossRef citations to date
0
Altmetric
Pharmacology

Limitations in contemporary self-reported medication adherence questionnaires: the concept and design of the General Medication Adherence Scale (GMAS) originating from a developing country

ORCID Icon &

References

  • Forbes CA, Deshpande S, Sorio-Vilela F, et al. A systematic literature review comparing methods for the measurement of patient persistence and adherence. Curr Med Res Opin 2018;34:1613-25
  • Perez-Escamilla B, Franco-Trigo L, Moullin JC, et al. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence 2015;9:569-78
  • Dunbar-Jacob J, Sereika SM, Houze M, et al. Accuracy of measures of medication adherence in a cholesterol-lowering regimen. West J Nurs Res 2012;34:578-97
  • Nori AY, Ali MSAK, Ibrahim B, et al. Modifying the Morisky medication adherence scale by adapting two items from the brief medication questionnaire to fit assessing the overall adherence to polypharmacy regimen of cardiac patients. Glob Heart 2014;9:e313
  • Nordstrom BL, Simeone JC, Zhao Z, et al. Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary intervention. Am J Cardiovasc Drugs 2013;13:263-71
  • Shalansky SJ, Levy AR, Ignaszewski AP. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 2004;38:1363-8
  • Abbas A, Kachela B, Arif JM, et al. Assessment of medication adherence and knowledge regarding the disease among ambulatory patients with diabetes mellitus in Karachi, Pakistan. J Young Pharm 2015;7:328-40
  • Abbas A. Evidence based improvements in clinical pharmacy clerkship program in undergraduate pharmacy education: the Evidence Based Improvement (EBI) initiative. Pharmacy 2014;2:270-5
  • Naqvi AA. Evolution of clinical pharmacy teaching practices in Pakistan. Arch Pharma Pract 2016;7:26-7
  • Stolpe S, Kroes MA, Webb N, et al. A systematic review of insulin adherence measures in patients with diabetes. J Manag Care Spec Pharm 2016;22:1224-46
  • Naqvi AA, Naqvi SBS, Shahid S, et al. Barriers to rehabilitation treatment among poliomyelitis infected patients in Karachi, Pakistan: a mix-methods study. Khyber Med Univ J 2016;8:12-21
  • Hussain M, Naqvi SBS, Khan MA, et al. Direct cost of treatment of diabetes mellitus type 2 in Pakistan. Int J Pharm Pharm Sci 2014;6:261-4
  • Rizvi M, Naqvi BS, Abbas A. Financial burden of pulmonary tuberculosis (TB) in Pakistan. World J Pharm Sci 2014;4:65-78
  • Naqvi AA, Naqvi SB, Zehra F, et al. The cost of poliomyelitis: lack of cost-of-illness studies on poliomyelitis rehabilitation in Pakistan. Arch Pharma Pract 2016;7:182-4
  • Naqvi AA, Hassali MA, Rizvi M, et al. Development and validation of a novel General Medication Adherence Scale (GMAS) for chronic illness patients in Pakistan. Front Pharmacol 2018;9:1124

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.